How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
28
UAL Quote, Financials, Valuation and Earnings
Last price:
$66.99
Seasonality move
:
-6.75%
Day range:
$65.26 - $67.32
52-week range:
$37.02 - $116.00
Dividend yield:
0%
P/E ratio:
5.95x
P/S ratio:
0.38x
P/B ratio:
1.69x
Volume:
6.8M
Avg. volume:
11.7M
1-year change:
27.09%
Market cap:
$21.3B
Revenue:
$57.1B
EPS (TTM):
$10.97
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $15.4B | $24.6B | $45B | $53.7B | $57.1B | |
| Revenue Growth (YoY) | -64.51% | 60.43% | 82.49% | 19.49% | 6.23% | |
| Cost of Revenues | $20.4B | $23.9B | $34.3B | $38.5B | $40.6B | |
| Gross Profit | -$5B | $721M | $10.6B | $15.2B | $16.5B | |
| Gross Profit Margin | -32.76% | 2.93% | 23.67% | 28.3% | 28.9% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $459M | $677M | $1.5B | $2B | $2.2B | |
| Other Inc / (Exp) | -$2.4B | $3.4B | -$112M | -$826M | -$364M | |
| Operating Expenses | $409M | $5.1B | $8.2B | $10B | $11.3B | |
| Operating Income | -$5.4B | -$4.4B | $2.5B | $5.2B | $5.2B | |
| Net Interest Expenses | $942M | $1.5B | $1.4B | $947M | $676M | |
| EBT. Incl. Unusual Items | -$8.8B | -$2.6B | $990M | $3.4B | $4.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.8B | -$593M | $253M | $769M | $1B | |
| Net Income to Company | -$7.1B | -$2B | $737M | $2.6B | $3.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.1B | -$2B | $737M | $2.6B | $3.1B | |
| Basic EPS (Cont. Ops) | -$25.30 | -$6.10 | $2.26 | $7.98 | $9.58 | |
| Diluted EPS (Cont. Ops) | -$25.30 | -$6.10 | $2.23 | $7.89 | $9.45 | |
| Weighted Average Basic Share | $279.4M | $321.9M | $326.4M | $327.8M | $328.6M | |
| Weighted Average Diluted Share | $279.4M | $321.9M | $330.1M | $331.9M | $333.2M | |
| EBITDA | -$5.3B | $1.5B | $5.1B | $7.8B | $8.5B | |
| EBIT | -$7.8B | -$980M | $2.7B | $5.2B | $5.6B | |
| Revenue (Reported) | $15.4B | $24.6B | $45B | $53.7B | $57.1B | |
| Operating Income (Reported) | -$5.4B | -$4.4B | $2.5B | $5.2B | $5.2B | |
| Operating Income (Adjusted) | -$7.8B | -$980M | $2.7B | $5.2B | $5.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | $7.6B | $11.4B | $12.5B | $13.2B | |
| Revenue Growth (YoY) | -59.63% | 134.9% | 51.06% | 9.71% | 5.37% | |
| Cost of Revenues | $5B | $7.3B | $9.2B | $9.8B | $9.9B | |
| Gross Profit | -$1.8B | $293M | $2.2B | $2.7B | $3.3B | |
| Gross Profit Margin | -55.85% | 3.87% | 19.14% | 21.85% | 25.16% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $85M | $226M | $403M | $480M | $496M | |
| Other Inc / (Exp) | -$474M | $27M | $51M | -$60M | $123M | |
| Operating Expenses | -$851M | $1.7B | $2.2B | $2.6B | $2.8B | |
| Operating Income | -$948M | -$1.4B | -$29M | $112M | $502M | |
| Net Interest Expenses | $329M | $395M | $278M | $216M | $144M | |
| EBT. Incl. Unusual Items | -$1.8B | -$1.8B | -$256M | -$164M | $478M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$394M | -$374M | -$62M | -$40M | $91M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.4B | -$1.4B | -$194M | -$124M | $387M | |
| Basic EPS (Cont. Ops) | -$4.29 | -$4.24 | -$0.59 | -$0.38 | $1.18 | |
| Diluted EPS (Cont. Ops) | -$4.29 | -$4.24 | -$0.59 | -$0.38 | $1.16 | |
| Weighted Average Basic Share | $316.6M | $325M | $327.4M | $328.3M | $327.7M | |
| Weighted Average Diluted Share | $316.6M | $325M | $327.4M | $328.3M | $333M | |
| EBITDA | -$1.4B | -$1.4B | $192M | $229M | $786M | |
| EBIT | -$1.4B | -$1.4B | $192M | $229M | $786M | |
| Revenue (Reported) | $3.2B | $7.6B | $11.4B | $12.5B | $13.2B | |
| Operating Income (Reported) | -$948M | -$1.4B | -$29M | $112M | $502M | |
| Operating Income (Adjusted) | -$1.4B | -$1.4B | $192M | $229M | $786M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.6B | $29B | $48.8B | $54.8B | $57.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $18.3B | $26.2B | $36.3B | $39.1B | $40.7B | |
| Gross Profit | -$7.7B | $2.8B | $12.5B | $15.8B | $17.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $249M | $818M | $1.7B | $2.1B | $2.2B | |
| Other Inc / (Exp) | -$1.8B | $2.1B | -$88M | -$937M | -$181M | |
| Operating Expenses | -$2.2B | $5.8B | $8.7B | $10.5B | $11.5B | |
| Operating Income | -$5.5B | -$3B | $3.8B | $5.3B | $5.6B | |
| Net Interest Expenses | $1.1B | $1.6B | $1.3B | $885M | $604M | |
| EBT. Incl. Unusual Items | -$8.5B | -$2.6B | $2.5B | $3.5B | $4.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.7B | -$573M | $566M | $790M | $1.2B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6.7B | -$2B | $1.9B | $2.7B | $3.7B | |
| Basic EPS (Cont. Ops) | -$22.49 | -$6.12 | $5.88 | $8.20 | $11.13 | |
| Diluted EPS (Cont. Ops) | -$22.80 | -$6.14 | $5.82 | $8.09 | $10.97 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$7.3B | -$916M | $4.2B | $5.2B | $6.1B | |
| EBIT | -$7.3B | -$916M | $4.2B | $5.2B | $6.1B | |
| Revenue (Reported) | $10.6B | $29B | $48.8B | $54.8B | $57.7B | |
| Operating Income (Reported) | -$5.5B | -$3B | $3.8B | $5.3B | $5.6B | |
| Operating Income (Adjusted) | -$7.3B | -$916M | $4.2B | $5.2B | $6.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | $7.6B | $11.4B | $12.5B | $13.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $5B | $7.3B | $9.2B | $9.8B | $9.9B | |
| Gross Profit | -$1.8B | $293M | $2.2B | $2.7B | $3.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $85M | $226M | $403M | $480M | $496M | |
| Other Inc / (Exp) | -$474M | $27M | $51M | -$60M | $123M | |
| Operating Expenses | -$851M | $1.7B | $2.2B | $2.6B | $2.8B | |
| Operating Income | -$948M | -$1.4B | -$29M | $112M | $502M | |
| Net Interest Expenses | $329M | $395M | $278M | $216M | $144M | |
| EBT. Incl. Unusual Items | -$1.8B | -$1.8B | -$256M | -$164M | $478M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$394M | -$374M | -$62M | -$40M | $91M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.4B | -$1.4B | -$194M | -$124M | $387M | |
| Basic EPS (Cont. Ops) | -$4.29 | -$4.24 | -$0.59 | -$0.38 | $1.18 | |
| Diluted EPS (Cont. Ops) | -$4.29 | -$4.24 | -$0.59 | -$0.38 | $1.16 | |
| Weighted Average Basic Share | $316.6M | $325M | $327.4M | $328.3M | $327.7M | |
| Weighted Average Diluted Share | $316.6M | $325M | $327.4M | $328.3M | $333M | |
| EBITDA | -$1.4B | -$1.4B | $192M | $229M | $786M | |
| EBIT | -$1.4B | -$1.4B | $192M | $229M | $786M | |
| Revenue (Reported) | $3.2B | $7.6B | $11.4B | $12.5B | $13.2B | |
| Operating Income (Reported) | -$948M | -$1.4B | -$29M | $112M | $502M | |
| Operating Income (Adjusted) | -$1.4B | -$1.4B | $192M | $229M | $786M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.3B | $18.3B | $7.2B | $6.1B | $8.8B | |
| Short Term Investments | $414M | $123M | $9.2B | $8.3B | $5.7B | |
| Accounts Receivable, Net | $1.3B | $1.7B | $1.8B | $1.9B | $2.2B | |
| Inventory | $932M | $983M | $1.1B | $1.6B | $1.6B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $635M | $745M | $689M | $640M | $673M | |
| Total Current Assets | $14.8B | $21.8B | $20.1B | $18.5B | $18.9B | |
| Property Plant And Equipment | $36B | $36.7B | $38.3B | $43.7B | $46.7B | |
| Long-Term Investments | $1B | $1.4B | $1.4B | $1.6B | $1.3B | |
| Goodwill | $4.5B | $4.5B | $4.5B | $4.5B | $4.5B | |
| Other Intangibles | $2.8B | $2.8B | $2.8B | $2.7B | $2.7B | |
| Other Long-Term Assets | $218M | $213M | $210M | $245M | -- | |
| Total Assets | $59.5B | $68.2B | $67.4B | $71.1B | $74.1B | |
| Accounts Payable | $1.6B | $2.6B | $3.4B | $3.8B | $4.2B | |
| Accrued Expenses | $2B | $2.1B | $2B | $2.9B | $3.3B | |
| Current Portion Of Long-Term Debt | $1.9B | $3B | $2.9B | $4.2B | $3.5B | |
| Current Portion Of Capital Lease Obligations | $794M | $632M | $665M | $576M | $467M | |
| Other Current Liabilities | $724M | $1.4B | $802M | $806M | $948M | |
| Total Current Liabilities | $12.7B | $18.3B | $20B | $22.2B | $23.3B | |
| Long-Term Debt | $24.8B | $30.4B | $28.3B | $27.4B | $25.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $53.6B | $63.1B | $60.5B | $61.8B | $61.4B | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | |
| Other Common Equity Adj | -$1.1B | -$942M | $175M | -$62M | $188M | |
| Common Equity | $6B | $5B | $6.9B | $9.3B | $12.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $6B | $5B | $6.9B | $9.3B | $12.7B | |
| Total Liabilities and Equity | $59.5B | $68.2B | $67.4B | $71.1B | $74.1B | |
| Cash and Short Terms | $11.7B | $18.4B | $16.4B | $14.4B | $14.5B | |
| Total Debt | $26.7B | $33.4B | $31.2B | $31.7B | $28.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $12.7B | $18.5B | $7.6B | $8.4B | $9.4B | |
| Short Term Investments | $309M | $211M | $9.5B | $5.6B | $6B | |
| Accounts Receivable, Net | $1.4B | $2.1B | $2.3B | $2.3B | $2.3B | |
| Inventory | $918M | $1.1B | $1.2B | $1.7B | $1.6B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $483M | $762M | $787M | $730M | $929M | |
| Total Current Assets | $16B | $22.6B | $21.6B | $18.7B | $20.1B | |
| Property Plant And Equipment | $36.4B | $36.5B | $39.9B | $44.4B | $47.5B | |
| Long-Term Investments | $1.1B | $1.4B | $1.3B | $1.4B | $1.2B | |
| Goodwill | $4.5B | $4.5B | $4.5B | $4.5B | $4.5B | |
| Other Intangibles | $2.8B | $2.8B | $2.8B | $2.7B | $2.7B | |
| Other Long-Term Assets | $218M | $214M | $225M | $244M | -- | |
| Total Assets | $61.7B | $69B | $70.4B | $71.9B | $76.1B | |
| Accounts Payable | $1.8B | $3B | $3.9B | $4.3B | $4.7B | |
| Accrued Expenses | $2.3B | $2B | $2B | $2.1B | $2.4B | |
| Current Portion Of Long-Term Debt | $1.8B | $3B | $3.2B | $4B | $3.3B | |
| Current Portion Of Capital Lease Obligations | $802M | $602M | $685M | $674M | $506M | |
| Other Current Liabilities | $724M | $1.8B | $926M | $973M | $989M | |
| Total Current Liabilities | $14.2B | $21.8B | $23.6B | $24.8B | $25.8B | |
| Long-Term Debt | $25.8B | $29.7B | $27.5B | $23.1B | $24.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $56.5B | $65.4B | $63.7B | $62.7B | $63.5B | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | |
| Other Common Equity Adj | -$1.1B | -$937M | $161M | -$81M | $164M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $5.2B | $3.6B | $6.7B | $9.2B | $12.6B | |
| Total Liabilities and Equity | $61.7B | $69B | $70.4B | $71.9B | $76.1B | |
| Cash and Short Terms | $13B | $18.7B | $17.2B | $14B | $15.3B | |
| Total Debt | $27.6B | $32.7B | $30.7B | $27B | $27.7B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.1B | -$2B | $737M | $2.6B | $3.1B | |
| Depreciation & Amoritzation | $2.5B | $2.5B | $2.5B | $2.7B | $2.9B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $135M | -$448M | -$158M | -$100M | $280M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$4.1B | $2.1B | $6.1B | $6.9B | $9.4B | |
| Capital Expenditures | $1.7B | $2.1B | $4.8B | $7.2B | $5.6B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $50M | -$1.7B | -$13.8B | -$6.1B | -$2.7B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $15.7B | $11.1B | $736M | $2.4B | $6.1B | |
| Long-Term Debt Repaid | -$4.4B | -$5.2B | -$4B | -$4.2B | -$10.1B | |
| Repurchase of Common Stock | -$353M | -- | -- | -- | -$162M | |
| Other Financing Activities | -$20M | -$27M | -$74M | -$32M | -$21M | |
| Cash From Financing | $13B | $6.4B | -$3.3B | -$1.9B | -$4.2B | |
| Beginning Cash (CF) | $2.9B | $11.7B | $18.5B | $7.4B | $6.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8.9B | $6.8B | -$11.1B | -$1.1B | $2.6B | |
| Ending Cash (CF) | $11.7B | $18.5B | $7.4B | $6.3B | $8.9B | |
| Levered Free Cash Flow | -$5.9B | -$40M | $1.2B | -$260M | $3.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $426M | $1.5B | $3.1B | $2.8B | $3.7B | |
| Capital Expenditures | $444M | $402M | $1.8B | $1.4B | $1.2B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$329M | -$430M | -$2B | $1.4B | -$1.5B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.3B | -- | $288M | $3.1B | -- | |
| Long-Term Debt Repaid | -$569M | -$783M | -$820M | -$5B | -$1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$349M | |
| Other Financing Activities | -- | -$73M | -$31M | -$18M | -$94M | |
| Cash From Financing | $1.3B | -$856M | -$563M | -$1.9B | -$1.5B | |
| Beginning Cash (CF) | $11.7B | $18.5B | $7.4B | $6.3B | $8.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.4B | $190M | $611M | $2.4B | $791M | |
| Ending Cash (CF) | $13.1B | $18.7B | $8B | $8.7B | $9.7B | |
| Levered Free Cash Flow | -$18M | $1.1B | $1.3B | $1.5B | $2.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$3.8B | $3.1B | $7.7B | $6.6B | $10.3B | |
| Capital Expenditures | $212M | $2.1B | $6.3B | $6.7B | $5.5B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $1.3B | -$1.8B | -$15.4B | -$2.7B | -$5.6B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $14.2B | $9.8B | $1B | $5.2B | -- | |
| Long-Term Debt Repaid | -$4.8B | -$5.4B | -$4B | -$8.5B | -$6.1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$100M | -$32M | -$19M | -$97M | |
| Cash From Financing | $12.1B | $4.2B | -$3.1B | -$3.3B | -$3.7B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.6B | $5.6B | -$10.7B | $653M | $1.1B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$4B | $1.1B | $1.5B | -$77M | $4.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $426M | $1.5B | $3.1B | $2.8B | $3.7B | |
| Capital Expenditures | $444M | $402M | $1.8B | $1.4B | $1.2B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$329M | -$430M | -$2B | $1.4B | -$1.5B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.3B | -- | $288M | $3.1B | -- | |
| Long-Term Debt Repaid | -$569M | -$783M | -$820M | -$5B | -$1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$349M | |
| Other Financing Activities | -- | -$73M | -$31M | -$18M | -$94M | |
| Cash From Financing | $1.3B | -$856M | -$563M | -$1.9B | -$1.5B | |
| Beginning Cash (CF) | $11.7B | $18.5B | $7.4B | $6.3B | $8.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.4B | $190M | $611M | $2.4B | $791M | |
| Ending Cash (CF) | $13.1B | $18.7B | $8B | $8.7B | $9.7B | |
| Levered Free Cash Flow | -$18M | $1.1B | $1.3B | $1.5B | $2.5B | |
Get UAL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UAL
Sector
P/E ratio
5.95x
16.44x
PEG ratio
0.17x
0.27x
P/B ratio
1.69x
1.59x
Price / LTM sales
0.38x
0.87x
Growth Metrics
UAL
Sector
Revenue growth
5.37%
3.04%
Earnings growth
62.98%
6.53%
Revenue (5-year growth)
5.7%
4.4%
Earnings forecast
$0.74
$0.29
Profitability
UAL
Sector
Profitability FY 2024
$16.5B
$409.9M
Return on invested capital
9.54%
5.67%
Return on assets
4.97%
3.55%
Return on equity
32.41%
8.62%
Earnings Date
Last Earnings Date
Apr
15
Next Earnings Date
Jul
17
Estimated Next Earnings Date
Jul
15
Balance Sheet
UAL
Sector
Total cash
$15.3B
$163.9M
Short term investments
$5.7B
$39.4M
Total assets
$74.1B
$1.9B
Long term debt
$27.7B
$275.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
61
AGX alert for Apr 23
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
